Catherine Kimber
LightNews LightNews
banner
thrinaline.bsky.social
Catherine Kimber
@thrinaline.bsky.social
73 followers 430 following 52 posts
Proud to work for the NHS. Trying to adhere to sustainable travel in a small and imperfect way. Loves books, gardening, singing and Jet Lag the Game. Extremely grumpy and critical member of the Church of England.
Posts Replies Media Videos
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
by Arcuri et al.
www.stemcellevidence.com/articles/410...
#MedSky
Image showing a PICO summary for: Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis by Arcuri et al. featured in the Stem Cell Evidence Alert - November 2025
November 25, 2025 at 5:26 PM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
The #StemCellEvidence monthly alert is out!

See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
Image showing an extract of the Stem Cell Evidence Alert - November 2025
November 24, 2025 at 11:33 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...)
by Ru et al.
www.stemcellevidence.com/articles/409...
#MedSky
Image showing a PICO summary for: Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation by Ru et al. featured in the Stem Cell Evidence Alert - October 2025
November 10, 2025 at 11:13 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT
by Toya et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT by Toya et al. featured in the Stem Cell Evidence Alert - October 2025
November 11, 2025 at 7:00 AM
Reposted by Catherine Kimber
transfusionlib.bsky.social
Thank you so much @isbt.bsky.social!

We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
Image showing an ISBT Award 2025 received by the Transfusion Evidence Round-Up Team
November 10, 2025 at 2:05 PM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
Image showing a PICO summary for: Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation by Lee et al. featured in the Stem Cell Evidence Alert - October 2025
November 7, 2025 at 1:10 PM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
Image showing a PICO summary for: Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study by Kogler et al. featured in the Stem Cell Evidence Alert - October 2025
November 6, 2025 at 2:06 PM
Reposted by Catherine Kimber
adamchase.bsky.social
we have been hard at work for almost a year now on this series about the world's largest annual scavenger hunt

maybe give the trailer a watch and if u dig it you can watch on Nebula starting November 5!
nebula.tv Nebula @nebula.tv · Oct 22
The hunt is just beginning — Scav comes to Nebula Nov. 5
October 22, 2025 at 9:24 PM
Reposted by Catherine Kimber
nathanley.com
I made a detailed explainer video (with Q&A) for the proposed new junction in Abingdon to prioritise walking, cycling, wheeling, and generally make it a more pleasant town centre

It won't work on the hardcore antis but I couldn't bear the lies going around!

youtu.be/9k4VjunZhqQ?...
Abingdon Town Centre Junction: A Redesign to Prioritise Cycling, Walking, and Active Travel (NCN5)
YouTube video by Cllr Nathan Ley
youtu.be
October 5, 2025 at 7:20 PM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Neurological manifestations of chronic graft versus host disease
by Koren et al.
www.stemcellevidence.com/articles/408...
#MedSky
Image showing a PICO summary for: Neurological manifestations of chronic graft versus host disease by Koren et al. featured in the Stem Cell Evidence Alert - September 2025
October 7, 2025 at 6:38 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
by Stelljes et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial by Stelljes et al. featured in the Stem Cell Evidence Alert - September 2025
September 30, 2025 at 9:56 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party
by Berning et al.
www.stemcellevidence.com/articles/408...
#MedSky
Image showing a PICO summary for: Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party by Berning et al. featured in the Stem Cell Evidence Alert - September 2025
October 1, 2025 at 8:11 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers
by Caballero-Velázquez et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers by Caballero-Velázquez et al. featured in the Stem Cell Evidence Alert - September 2025
October 2, 2025 at 6:30 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...)
by Capes et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation by Capes et al. featured in the Stem Cell Evidence Alert - September 2025
October 3, 2025 at 11:03 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
www.stemcellevidence.com/articles/408...
#MedSky
Image showing a PICO summary for: Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT by Hernández-Boluda et al. featured in the Stem Cell Evidence Alert - September 2025
October 6, 2025 at 8:51 AM
Reposted by Catherine Kimber
transfusionlib.bsky.social
New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025

The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A #SystematicReview and #MetaAnalysis
by Chen et al.
www.stemcellevidence.com/articles/387...
#MedSky
Image showing a PICO summary for: The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A #SystematicReview and #MetaAnalysis by Chen et al. featured in the Transfusion Evidence Round-Up: Blood Cancer Awareness Month 2025
September 23, 2025 at 1:16 PM
Reposted by Catherine Kimber
transfusionlib.bsky.social
From the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa (...)
by Garcia-Manero et al.
www.transfusionevidencelibrary.com/articles/403...
#MedSky
Image showing a PICO summary for: Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial by Garcia-Manero et al. featured in the Transfusion Evidence Round-UP: Blood Cancer Awareness Month 2025
September 24, 2025 at 9:16 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
by Zeiser et al.

www.stemcellevidence.com/articles/405...

#MedSky
Image showing a PICO summary for: Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study by Zeiser et al. Featured in Stem Cell Evidence Alert – August 2025
September 12, 2025 at 11:46 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
by Perales et al.

www.stemcellevidence.com/articles/406...

#MedSky
Image showing a PICO summary for: Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis by Perales et al. Featured in Stem Cell Evidence Alert – August 2025
September 11, 2025 at 1:04 PM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
From the #StemCellEvidence Alert:

Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
By Oran et al.

www.stemcellevidence.com/articles/407...
#MedSky
September 10, 2025 at 11:52 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse (...)
by Montagna et al.
www.stemcellevidence.com/articles/405...
#MedSky
Image showing a PICO summary for: Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation: study rational and design by Montagna et al. featured in the Stem Cell Evidence Alert - August 2025
September 9, 2025 at 10:31 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept
by Koura et al.
www.stemcellevidence.com/articles/405...
#MedSky
Image showing a PICO summary for: A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept by Koura et al. featured in the Stem Cell Evidence Alert - August 2025
September 5, 2025 at 5:52 AM
Reposted by Catherine Kimber
transfusionlib.bsky.social
New from #Transfusion Evidence Library:

Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions
by Karafin et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions by Karafin et al. featured in the Transfusion Evidence Alert - August 2025
September 4, 2025 at 10:29 AM
Reposted by Catherine Kimber
transfusionlib.bsky.social
From the #Transfusion Evidence Alert:

Efficacy and safety of #tranexamicacid administration for subarachnoid hemorrhage: a #systematicreview and #meta-analysis
by Imai et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis by Imai et al. featured in the Transfusion Evidence Alert - August 2025
September 3, 2025 at 7:12 AM
Reposted by Catherine Kimber
stemcellevidence.bsky.social
New from #StemCellEvidence:

Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT
by Giebel et al.
www.stemcellevidence.com/articles/406...
#MedSky
Image showing a PICO summary for: Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT by Giebel et al. featured in the Stem Cell Evidence Alert - August 2025
September 3, 2025 at 7:40 AM